Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 89,996 |
|
|||||
| News | - | ||||||
| Day High | 2.595 | Low High |
|||||
| Day Low | 2.4096 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ProKidney Corporation | PROK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.12 | 4.96% | 2.54 | 10:58:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.46 | 2.4096 | 2.595 | 2.42 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 869 | 89,996 | $ 2.52 | $ 227,167 | - | 1.12 - 13.51 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:58:27 | 2 | $ 2.55 | USD |
ProKidney Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.18B | 235.43M | - | 0 | -35.47M | -0.15 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ProKidney News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PROK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.16 | 2.595 | 2.03 | 2.27 | 380,667 | 0.38 | 17.59% |
| 1 Month | 1.46 | 3.37 | 1.45 | 2.33 | 1,255,447 | 1.08 | 73.97% |
| 3 Months | 1.25 | 3.37 | 1.22 | 1.99 | 766,624 | 1.29 | 103.20% |
| 6 Months | 1.70 | 3.37 | 1.12 | 1.80 | 812,424 | 0.84 | 49.41% |
| 1 Year | 9.23 | 13.51 | 1.12 | 3.58 | 646,685 | -6.69 | -72.48% |
| 3 Years | 9.40 | 14.19 | 1.12 | 4.55 | 410,588 | -6.86 | -72.98% |
| 5 Years | 9.40 | 14.19 | 1.12 | 4.55 | 410,588 | -6.86 | -72.98% |
ProKidney Description
| ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. |
